9 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... indicate preferred treatment ... limitation, further evaluation ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Medical Treatment ... Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... Algorithm #Management #Pulmonary ... #SAMA #ICS #Pharmacology
Salicylate Toxicity - Diagnosis and Management

Consider if:
1) Patient is hot and altered
2) You see tachypnea with
Salicylate Toxicity ... respiratory cause 3) Labs ... , Diaphoresis, Pulmonary ... edema, Shock Labs ... diagnosis #management #Treatment
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
starting amiodarone treatment ... pneumonia - Pulmonary ... Labs: • Nonspecific ... macrophages Treatment ... #Pulmonary #diagnosis
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
are excellent at evaluating ... with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... icu #clinical #pharmacology
Testicular Cancer - Treatment Related Toxicities

Bleomycin, Cisplatin, Etoposide, lfosfamide
Tinnitus & Hearing Loss
Neurotoxicity
Pulmonary Fibrosis
Hypotension
Nephrotoxicity
Skin Hyperpigmentation
Hemorrhagic Cystitis
Myelosuppression
Peripheral Neuropathy

Ashley
Testicular Cancer - Treatment ... Neurotoxicity Pulmonary ... #chemotherapy #toxicity ... toxicology #Toxicities #pharmacology
Lithium Therapy for Bipolar Disorder 
Toxicity Levels: 
 - Mild (1-1.5 mEq/L) 
 - Moderate (1.6-2.5
Bipolar Disorder Toxicity ... , weight gain Toxicity ... maintenance agent for treatment ... patients to go to the lab ... #Pharmacology #
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
syndromes current treatment ... risk of clonal evolution ... influence outcomes and treatment ... cardiovascular or pulmonary ... risk of organ toxicity